T. Jensen

发表

Low‐dose hydrocortisone in patients with COVID‐19 and severe hypoxia (COVID STEROID) trial—Protocol and statistical analysis plan

V. Jha, S. Myatra, A. S. Andreasen, 2020, Acta anaesthesiologica Scandinavica.

Low‐dose hydrocortisone in patients with COVID‐19 and severe hypoxia: The COVID STEROID randomised, placebo‐controlled trial

V. Jha, S. Myatra, A. S. Andreasen, 2021, Acta anaesthesiologica Scandinavica.

Long-term mortality and health-related quality of life of lower versus higher oxygenation targets in ICU patients with severe hypoxaemia

T. Lange, J. Wetterslev, L. Poulsen, 2022, Intensive Care Medicine.

Long-term mortality and health-related quality of life of lower versus higher oxygenation targets in ICU patients with severe hypoxaemia

T. Lange, J. Wetterslev, L. Poulsen, 2022, Intensive Care Medicine.

Restriction of Intravenous Fluid in ICU Patients with Septic Shock.

M. Nalos, J. Laake, S. Jakob, 2022, The New England journal of medicine.

Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial.

F. Kapadia, V. Jha, J. Divatia, 2021, JAMA.

Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxia: an international, randomized, blinded trial

F. Kapadia, V. Jha, J. Divatia, 2021, medRxiv.

Effects of magnesium, phosphate, or zinc supplementation in intensive care unit patients—A systematic review and meta‐analysis

A. Perner, T. Thomsen, M. Møller, 2022, Acta anaesthesiologica Scandinavica.

Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements

S. Møller, T. Jensen, P. Manniche, 1991, Acta psychiatrica Scandinavica.